Neupro (UCB) FDA approved for advanced Parkinsons and RLS

advanced Parkinsons and RLS Neupro(rotigotine transdermal system) from UCB/Schwarz is FDA approved as a therapy to treat the signs and symptoms of advanced stage idiopathic Parkinson's Disease and as a treatment for moderate-to-severe primary Restless Legs Syndrome. Neupro was previously approved in the USA as a therapy to treat the signs and symptoms of early stage idiopathic Parkinson's disease.